Difficulty: Medium
Average Score: 85%
Practice
Which of the following is/are true:
Correct answer
C
Rationale
The correct answer is C) A person who has had a severe local reaction to the first dose of anthrax vaccine should not receive a second dose.
Rationale:
This statement is true because individuals who experience a severe local reaction to the first dose of the anthrax vaccine are at an increased risk of developing a more severe reaction if they receive a second dose. It is essential to consider the risk-benefit ratio when deciding on repeat vaccination in such cases to avoid potential harm to the individual.
Option A is incorrect because although immunoglobulins can be effective as post-exposure prophylaxis for certain infections, they are not typically used for anthrax. Anthrax post-exposure prophylaxis usually involves antibiotics.
Option B is incorrect because there is no contraindication to giving the anthrax vaccine at the same time as live vaccines. In general, vaccines can be administered simultaneously if needed, following standard guidelines.
Option D is incorrect because patients with HIV infection and a very low CD4 count are actually recommended to receive the anthrax vaccine due to their increased susceptibility to certain infections, including anthrax. Vaccination can help protect immunocompromised individuals from preventable diseases.
Educational Context:
Understanding the indications and contraindications for vaccines, particularly in special populations like those with severe reactions or immunocompromised individuals, is crucial for healthcare providers involved in infection control. It is important to follow evidence-based guidelines and recommendations to ensure safe and effective vaccination practices in various clinical scenarios.
Rationale:
This statement is true because individuals who experience a severe local reaction to the first dose of the anthrax vaccine are at an increased risk of developing a more severe reaction if they receive a second dose. It is essential to consider the risk-benefit ratio when deciding on repeat vaccination in such cases to avoid potential harm to the individual.
Option A is incorrect because although immunoglobulins can be effective as post-exposure prophylaxis for certain infections, they are not typically used for anthrax. Anthrax post-exposure prophylaxis usually involves antibiotics.
Option B is incorrect because there is no contraindication to giving the anthrax vaccine at the same time as live vaccines. In general, vaccines can be administered simultaneously if needed, following standard guidelines.
Option D is incorrect because patients with HIV infection and a very low CD4 count are actually recommended to receive the anthrax vaccine due to their increased susceptibility to certain infections, including anthrax. Vaccination can help protect immunocompromised individuals from preventable diseases.
Educational Context:
Understanding the indications and contraindications for vaccines, particularly in special populations like those with severe reactions or immunocompromised individuals, is crucial for healthcare providers involved in infection control. It is important to follow evidence-based guidelines and recommendations to ensure safe and effective vaccination practices in various clinical scenarios.